From the Journals
From the Journals
‘Deaths of despair’ rising, but only in the U.S.
This is not the case in 16 other industrialized nations.
From the Journals
Antibody mix may prevent COVID symptoms in some asymptomatic people
The results suggest new potential for monoclonal antibodies currently used for postexposure prophylaxis and treatment of symptomatic SARS-CoV-2....
Latest News
Open-label placebo improves symptoms in pediatric IBS and functional abdominal pain
Most children who received a regimen of sugar water reported an improvement in IBS-related discomfort.
From the Journals
Childhood trauma may influence vaccine hesitancy
Hesitancy was three times higher among people who had experienced four or more types of childhood trauma.
From the Journals
Men with hypersexual disorder may have oxytocin overload
Cognitive-behavioral therapy reduced both oxytocin levels and hypersexual behavior.
From the Journals
OTC melatonin supplement use rises fivefold over 20 years
The study was designed to evaluate the breadth of use of melatonin, rather than its effectiveness as a sleep aid.
From the Journals
Psychedelic therapy and suicide: A myth busted?
Effect sizes for reductions in suicidality were “large” at all acute time points, with standardized mean differences (SMD) ranging from -1.48 to -...
Latest News
What docs don’t know about the Disabilities Act can hurt them and patients
When physicians don’t provide access to medical care that patients with disabilities need, they put themselves at greater risk of lawsuits, fines...
From the Journals
Newly approved drug improves sleep onset in insomnia
The drug also was associated with improved daytime function.
From the Journals
Omicron subvariant 1.5 times more contagious than Omicron
The WHO hasn’t labeled BA.2 a “variant of concern” so far but will continue to monitor it.
From the Journals
Buprenorphine may curb opioid-induced respiratory depression
“I think this is an approach that works, and this study makes that clear,” said Dr. Geert Jan Groeneveld.